IGKV1D-22 and neoplasm: These extracellular microparticles are able to fuse with cancer and normal lung cells and inhibit tumor cell migration, as well as reduce inflammation in the tumor microenvironment by decreasing the release of S100A8/A9 and IL-6 [183].